Clinical Trial Update: OH2 Injection in Combination With HX008 for Melanoma. [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial is evaluating OH2 Injection in combination with HX008 for melanoma, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• HX008
• OH2 Injection

Snippet

Sponsor: Binhui Biopharmaceutical Co., Ltd. | Conditions: Melanoma | Phase 1, Phase 2 | Status: RECRUITING